Hydrophobic surfactant proteins in lung function and disease

New England Journal of Medicine

Volumn 347, Issue 26, 2002, Pages 2141-2148

  Whitsett, Jeffrey A ^a,b   Weaver, Timothy E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C;

CHRONIC LUNG DISEASE; DISEASE ASSOCIATION; GENE MUTATION; LUNG DISEASE; LUNG FUNCTION; NEONATAL RESPIRATORY DISTRESS SYNDROME; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW;

HUMANS; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL; MUTATION; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; RESPIRATORY PHYSIOLOGY;

EID: 0037180829     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra022387     Document Type: Review

References (41)

1. Johansson J, Curstedt T. Molecular structures and interactions of pulmonary surfactant components. Eur J Biochem 1997;244:675-93.
2. Dranoff G, Crawford AD, Sadelain M, et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994;264:713-6.
3. Robb L, Drinkwater CC, Metcalf D, et al. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci U S A 1995;92:9565-9.
4. Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999;190: 875-80.
5. Weaver TE, Conkright JJ. Function of surfactant proteins B and C. Annu Rev Physiol 2001;63:555-78.
6. Hawgood S, Derrick M, Poulain F. Structure and properties of surfactant protein B. Biochim Biophys Acta 1998;1408:150-60.
7. Johansson J. Structure and properties of surfactant protein C. Biochim Biophys Acta 1998;1408:161-72.
8. Weaver TE, Whitsett JA. Processing of hydrophobic pulmonary surfactant protein B in rat type II cells. Am J Physiol 1989;257: L100-L108.
9. Glasser SW, Korfhagen TR, Weaver TE, Pilot-Matias T, Fox JL, Whitsett JA. cDNA and deduced amino acid sequence of human pulmonary surfactant-associated proteolipid SPL(Phe). Proc Natl Acad Sci U S A 1987;84:4007-11.
10. Pryhuber GS, Hull WM, Fink I, McMahan MJ, Whitsett JA. Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity. Pediatr Res 1991;30:597-605.
11. Gregory TJ, Longmore WJ, Moxley MA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88:1976-81.
12. Greene KE, Wright JR, Steinberg KP, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999;160:1843-50.
13. Clark JC, Wert SE, Bachurski CJ, et al. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci U S A 1995;92:7794-8.
14. Vorbroker DK, Profitt SA, Nogee LM, Whitsett JA. Aberrant processing of surfactant protein C in hereditary SP-B deficiency. Am J Physiol 1995;268:L647-L656.
15. Stahiman MT, Gray MP, Falconieri MW, Whitsett JA, Weaver TE. Lamellar body formation in normal and surfactant protein B-deficient fetal mice. Lab Invest 2000;80:395-403.
16. Nogee LM, deMello DE, Dehner LP, Colten HR. Deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993;328:406-10.
17. Nogee LM, Wert SE, Proffit SA, Hull WM, Whitsett IA. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respit Crit Care Med 2000;161:973-81.
18. Tokieda K, Whitsett JA, Clark JC, et al. Pulmonary dysfunction in neonatal SP-B-deficient mice. Am J Physiol 1997;17:L875-L882.
19. Tokieda K, Iwamoto HS, Bachurski C, et al. Surfactant protein-B-deficient mice are susceptible to hyperoxic lung injury. Am J Respir Cell Mol Biol 1999;21:463-72.
20. Yusen RD, Cohen AH, Hamvas A. Normal lung function in subjects heterozygous for surfactant protein-B deficiency. Am J Respir Crit Care Med 1999;159:411-4.
21. Hamvas A, Nogee LM, Mallory GB Jr, et al. Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr 1997; 130:231-9.
22. Ballard PL, Nogee LM, Beers MF, et al. Partial deficiency of surfactant protein B in an infant with chronic lung disease. Pediatrics 1995;96:1046-52.
23. Dunbar AE III, Wert SE, Ikegami M, et al. Prolonged survival in hereditary surfactant protein B (SP-B) deficiency associated with a novel splicing mutation. Pediatr Res 2000;48:275-82.
24. Klein JM, Thompson MW, Snyder JM, et al. Transient surfactant protein B deficiency in a term infant with severe respiratory failure. J Pediatr 1998;132:244-8.
25. Warr RG, Hawgood S, Buckley DI, et al. Low molecular weight human pulmonary surfactant protein (SP5): Isolation, characterization and cDNA and amino acid sequences. Proc Natl Acad Sci U S A 1987;84:7915-9.
26. Glasser SW, Korfhagen TR, Weaver TE, et al. cDNA, deduced polypeptide structure and chromosomal assignment of human pulmonary surfactant proteolipid, SPL(pVal). J Biol Chem 1988;263:9-12.
27. Conkright JJ, Bridges JP, Na CL, et al. Secretion of surfactant protein C, an integral membrane protein, requires the N-terminal propeptide. J Biol Chem 2001;276:14658-64.
28. Curstedt T, Johansson J, Persson P, et al. Hydrophobic surfactant-associated peptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups. Proc Natl Acad Sci U S A 1990;87:2985-9.
29. Horowitz AD, Elledge B, Whitsett JA, Baatz JE. Effects of lung surfactant proteolipid SP-C on the organization of model membrane lipids: A fluorescence study. Biochim Biophys Acta 1992;1107:44-54.
30. Horowitz AD, Baatz JE, Whitsett JA. Lipid effects on aggregation of pulmonary surfactant protein SP-C studied by fluorescence energy transfer. Biochemistry 1993;32:9513-23.
31. Baatz JE, Smyth KL, Whitsett JA, Baxter C, Absolom DR. Structure and functions of a dimeric form of surfactant protein C: A Fourier transform infrared and surfactometry study. Chem Phys Lipids 1992;63:91-104.
32. Gustafsson M, Thyberg J, Naslund J, Eliasson E, Johansson J. Amyloid fibril formation by pulmonary surfactant protein C. FEBS Lett 1999;464: 138-42.
33. Horowitz AD, Moussavian B, Whitsett JA. Roles of SP-A, SP-B, and SP-C in modulation of lipid uptake by pulmonary epithelia] cells in vitro. Am J Physiol 1996;270:L69-L79.
34. Glasser SW, Burhans MS, Korfhagen TR, et al. Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc Natl Acad Sci U S A 2001; 98:6366-71.
35. Conkright JJ, Na CL, Weaver TE. Overexpression of surfactant protein-C mature peptide causes neonatal lethality in transgenic mice. Am J Respir Cell Mol Biol 2002;26:85-90.
36. Amin RS, Wert SE, Baughman RP, et al. Surfactant protein deficiency in familial interstitial lung disease. J Pediatr 2001;139:85-92.
37. Nogee LM, Dunbar AE III, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001;344:573-9.
38. Thomas AQ, Lane K, Phillips J III, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002;165:1322-8.
39. Whitsett JA. Genetic basis of familial interstitial lung disease: Misfolding or function of surfactant protein C? Am J Respir Crit Care Med 2002; 165:1201-2.
40. American Thoracic Society. Idiopathic pulmonary fibrosis: Diagnosis and treatment: International consensus statement. Am J Respir Crit Care Med 2000;161:646-64.
41. Dobson CM. The structural basis of protein folding and its links with human disease. Philos Trans R Soc Lond B Biol Sci 2001;356:133-45.